Literature DB >> 15514103

Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1.

Georg H Waetzig1, Philip Rosenstiel, Alexander Arlt, Andreas Till, Karen Bräutigam, Heiner Schäfer, Stefan Rose-John, Dirk Seegert, Stefan Schreiber.   

Abstract

The pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) plays a central role in inflammatory disorders. Transmembrane TNF-alpha and its two receptors are cleaved by the proteinase TNF-alpha converting enzyme (TACE), resulting in appreciable serum levels of soluble TNF-alpha and soluble TNF-alpha receptors (sTNFR1 and -2). The only known functions of sTNFR1 are to antagonize and buffer circulating TNF-alpha. Here, we present evidence that sTNFR1 exerts immunoregulatory functions by induction of apoptosis in monocytes through reverse signaling via transmembrane TNF-alpha. sTNFR1-induced apoptosis is independent of death receptor pathways but depends on autocrine transforming growth factor (TGF)-beta1 signaling through the mitogen-activated protein kinase p38alpha. This novel mechanism has implications for understanding the physiological role of sTNFR1 and for TNF-alpha-blocking therapies of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15514103     DOI: 10.1096/fj.04-2073fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  22 in total

Review 1.  [Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement].

Authors:  M Laudien; P Ambrosch; A Till; R Podschun; P Lamprecht
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

2.  ADAM17 regulates TNFα production by placental trophoblasts.

Authors:  R Ma; Y Gu; L J Groome; Y Wang
Journal:  Placenta       Date:  2011-10-20       Impact factor: 3.481

3.  Reduction of adhesion formation and promotion of wound healing after laminectomy by pharmacological inhibition of pro-inflammatory cytokines: an experimental study in the rat.

Authors:  Kjell Olmarker
Journal:  Eur Spine J       Date:  2010-07-10       Impact factor: 3.134

4.  Quantum dots trigger immunomodulation of the NFκB pathway in human skin cells.

Authors:  Amelia A Romoser; Patricia L Chen; J Michael Berg; Christopher Seabury; Ivan Ivanov; Michael F Criscitiello; Christie M Sayes
Journal:  Mol Immunol       Date:  2011-04-09       Impact factor: 4.407

5.  TNFRSF1B Is Associated with ANCA in IBD.

Authors:  Dalin Li; Mark S Silverberg; Talin Haritunians; Marla C Dubinsky; Carol Landers; Joanne M Stempak; Raquel Milgrom; Xiuqing Guo; Yii-Der Ida Chen; Jerome I Rotter; Kent D Taylor; Dermot P B McGovern; Stephan R Targan
Journal:  Inflamm Bowel Dis       Date:  2016-06       Impact factor: 5.325

6.  Inflammation and Trajectory of Renal Function in Community-Dwelling Older Adults.

Authors:  Shabnam Salimi; Michelle D Shardell; Stephen L Seliger; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2018-01-23       Impact factor: 5.562

7.  Anti-inflammatory activity of hyperimmune plasma in a lipopolysaccharide-mediated rat air pouch model of inflammation.

Authors:  Bryan E Essien; Michael Kotiw
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

8.  IL-22 levels are associated with Trichomonas vaginalis infection in the lower genital tract.

Authors:  Hadijat Moradeke Makinde; Reza Zariffard; Paria Mirmonsef; Richard M Novak; Olamide Jarrett; Alan L Landay; Gregory T Spear
Journal:  Am J Reprod Immunol       Date:  2013-02-27       Impact factor: 3.886

9.  Susceptibility of human iris stromal cells to herpes simplex virus 1 entry.

Authors:  John Baldwin; Paul J Park; Brian Zanotti; Erika Maus; Michael V Volin; Deepak Shukla; Vaibhav Tiwari
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

Review 10.  Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha.

Authors:  Marina Mata; Shuanglin Hao; David J Fink
Journal:  Neurosci Lett       Date:  2008-03-22       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.